Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Clinical trials sponsored by Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd., explained in plain language.
-
New pill shows promise for psoriatic arthritis pain
Disease control Not yet recruitingThis study tests a new capsule, TQH3906, for people with active psoriatic arthritis (PsA), a condition causing joint pain and skin patches. About 156 adults aged 18-70 will receive either the new drug, a placebo, or an active comparator to see if it improves symptoms like joint s…
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
New hope for Tough-to-Treat colorectal cancer: targeted drug TQB2102 enters Late-Stage trial
Disease control Not yet recruitingThis study tests a new drug called TQB2102 in people with advanced colorectal cancer that has a specific protein (HER2 IHC3+). Participants must have already tried and failed three standard chemotherapies. About 142 adults will be randomly assigned to receive either TQB2102 or an…
Phase: PHASE3 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC